Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
52%
OVERLAP
BY WEIGHT
24
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
48%
ALSO IN PBPH
PBPH
57
HOLDINGS
47%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus PBPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PBPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.2% | 16.9% | 8.2% |
|
ABBVIE INC | 7.7% | 7.4% | 7.4% |
|
JOHNSON & JOHNSON | 6.9% | 9.3% | 6.9% |
|
MERCK & CO. INC. | 6.8% | 5.2% | 5.2% |
|
GILEAD SCIENCES INC | 3.9% | 4.1% | 3.9% |
FTXH Overweight Relative to PBPH
|
PFIZER INC | 3.8% |
|
VIATRIS, INC. | 3.5% |
|
BIOGEN IDEC INC | 3.2% |
|
UNITED THERAPEUTICS CORP | 3.0% |
|
ZOETIS INC | 2.8% |
|
INCYTE CORP | 2.8% |
|
EXELIXIS INC | 2.2% |
|
REGENERON PHARMACEUTICALS | 2.1% |
 |
JAZZ PHARMACEUTICALS PLC | 2.0% |
|
HALOZYME THERAPEUTICS INC | 1.8% |
FTXH Underweight Relative to PBPH
|
ELI LILLY & CO | -8.7% |
 |
ASTRAZENECA PLC | -4.8% |
 |
NOVARTIS AG | -4.2% |
 |
NOVO NORDISK A/S-B | -2.5% |
|
JOHNSON & JOHNSON | -2.4% |
 |
SANOFI-AVENTIS | -1.9% |
|
GSK PLC | -1.8% |
 |
CSL LIMITED | -1.3% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -1.3% |
 |
ARGEN-X SE | -1.1% |